Stock listing
NASDAQ:ROIV Roivant Sciences Ltd. Stock
Home listing (NASDAQ) of Roivant Sciences Ltd.
Follow Roivant Sciences Ltd. into a list and get an email when it puts out news.
Share price · NASDAQ:ROIV
$36.91 USD -0.61 (-1.6%)
Close on Oct 30, 2026
- Day range
- $36.78 – $37.94 USDOct 30, 2026
- Volume
- 4.57M sharesOct 30, 2026
- Market cap
- $26.66B USDAt the close on Oct 30, 2026 · price × 722.3M shares outstanding
- 52-week range
- $19.30 – $42.50 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $277.7M USDMedian day 6.10M shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ROIV · Home | $36.91 USD | -0.61 (-1.6%) | 4,574,470 | $37.50 | $37.94 | $36.78 | $37.52 | Close on Oct 30, 2026 |
| Frankfurt:87S | €33.14 EUR | +0.90 (+2.8%) | — | €33.20 | €33.20 | €33.01 | €32.24 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:ROIV · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $36.91 | -0.61 | -1.6% | $37.50 | $37.94 | $36.78 | 4,574,470 | |
| $37.52 | +0.41 | +1.1% | $37.44 | $37.97 | $37.29 | 3,728,780 | |
| $37.11 | +0.57 | +1.6% | $36.43 | $37.13 | $36.16 | 5,477,394 | |
| $36.54 | +0.49 | +1.4% | $36.04 | $36.83 | $35.80 | 6,567,877 | |
| $36.05 | -0.44 | -1.2% | $36.66 | $36.91 | $35.66 | 9,868,526 | |
| $36.49 | -0.96 | -2.6% | $37.18 | $37.42 | $36.36 | 8,225,400 | |
| $37.45 | +0.65 | +1.8% | $36.68 | $38.49 | $36.68 | 13,451,200 | |
| $36.80 | +1.88 | +5.4% | $38.15 | $38.49 | $35.99 | 16,839,600 | |
| $34.92 | +0.22 | +0.6% | $35.00 | $35.52 | $34.38 | 3,670,500 | |
| $34.70 | +1.17 | +3.5% | $33.78 | $35.14 | $33.60 | 6,334,300 | |
| $33.53 | -0.51 | -1.5% | $34.12 | $34.12 | $33.23 | 4,923,400 | |
| $34.04 | +0.42 | +1.2% | $33.82 | $34.36 | $33.70 | 4,565,900 | |
| $33.62 | +0.27 | +0.8% | $33.14 | $34.09 | $33.00 | 4,293,700 | |
| $33.35 | -1.24 | -3.6% | $34.44 | $34.92 | $33.26 | 6,322,200 | |
| $34.59 | -0.85 | -2.4% | $34.92 | $35.41 | $34.55 | 4,732,100 | |
| $35.44 | +1.23 | +3.6% | $34.24 | $35.59 | $34.15 | 5,533,200 | |
| $34.21 | -0.54 | -1.6% | $34.28 | $34.56 | $33.32 | 6,403,900 | |
| $34.75 | -0.78 | -2.2% | $35.22 | $35.49 | $34.63 | 5,738,800 | |
| $35.53 | -0.25 | -0.7% | $35.86 | $36.34 | $34.75 | 5,737,700 | |
| $35.78 | +0.06 | +0.2% | $35.98 | $36.33 | $35.25 | 6,200,500 | |
| $35.72 | +0.22 | +0.6% | $35.61 | $36.00 | $35.19 | 4,365,800 | |
| $35.50 | -1.07 | -2.9% | $36.35 | $36.79 | $35.44 | 3,272,000 | |
| $36.57 | +0.07 | +0.2% | $36.77 | $36.96 | $36.23 | 5,282,400 | |
| $36.50 | -0.48 | -1.3% | $37.03 | $37.35 | $35.75 | 6,587,600 | |
| $36.98 | +1.18 | +3.3% | $35.65 | $37.25 | $35.28 | 6,970,800 | |
| $35.80 | -0.33 | -0.9% | $35.98 | $36.19 | $35.52 | 6,764,400 | |
| $36.13 | -0.69 | -1.9% | $36.64 | $36.75 | $35.91 | 5,659,500 | |
| $36.82 | -1.40 | -3.7% | $38.00 | $38.47 | $36.78 | 9,272,900 | |
| $38.22 | -0.77 | -2.0% | $38.73 | $39.17 | $38.11 | 6,752,500 | |
| $38.99 | -0.78 | -2.0% | $39.02 | $39.90 | $38.72 | 5,620,100 | |
| $39.77 | -0.21 | -0.5% | $40.11 | $40.71 | $39.72 | 32,196,300 | |
| $39.98 | +0.41 | +1.0% | $40.45 | $40.97 | $39.50 | 7,604,000 | |
| $39.57 | +0.07 | +0.2% | $39.77 | $40.45 | $39.17 | 6,181,200 | |
| $39.50 | -1.52 | -3.7% | $41.14 | $41.14 | $39.22 | 8,104,600 | |
| $41.02 | +0.20 | +0.5% | $40.64 | $41.60 | $40.44 | 7,592,500 | |
| $40.82 | -0.12 | -0.3% | $41.22 | $41.83 | $40.51 | 5,963,900 | |
| $40.94 | -0.87 | -2.1% | $41.27 | $41.41 | $40.22 | 6,534,000 | |
| $41.81 | +0.33 | +0.8% | $41.39 | $42.28 | $41.08 | 11,147,100 | |
| $41.48 | +6.55 | +18.8% | $39.98 | $42.50 | $38.41 | 24,662,900 | |
| $34.93 | +0.52 | +1.5% | $34.20 | $35.15 | $33.88 | 5,237,900 | |
| $34.41 | +0.23 | +0.7% | $34.35 | $34.43 | $33.67 | 6,859,200 | |
| $34.18 | -0.34 | -1.0% | $34.64 | $35.04 | $33.43 | 6,196,100 | |
| $34.52 | -0.12 | -0.3% | $34.64 | $34.95 | $34.26 | 6,905,900 | |
| $34.64 | -0.07 | -0.2% | $34.83 | $35.34 | $34.02 | 39,466,600 | |
| $34.71 | -2.87 | -7.6% | $37.01 | $37.13 | $34.69 | 8,765,000 | |
| $37.58 | +0.83 | +2.3% | $36.85 | $37.81 | $36.50 | 4,920,800 | |
| $36.75 | +0.28 | +0.8% | $36.93 | $36.93 | $36.32 | 5,260,300 | |
| $36.47 | +0.11 | +0.3% | $36.82 | $37.29 | $36.31 | 4,481,403 | |
| $36.36 | +0.06 | +0.2% | $36.22 | $36.57 | $35.71 | 5,117,294 | |
| $36.30 | -0.54 | -1.5% | $37.03 | $37.18 | $36.23 | 6,185,500 | |
| $36.84 | -0.56 | -1.5% | $36.91 | $37.55 | $36.68 | 3,127,800 | |
| $37.40 | +0.03 | +0.1% | $37.83 | $37.97 | $36.75 | 5,814,700 | |
| $37.37 | +1.13 | +3.1% | $35.91 | $37.46 | $35.86 | 6,411,100 | |
| $36.24 | +0.04 | +0.1% | $36.22 | $37.19 | $35.65 | 7,729,900 | |
| $36.20 | -0.08 | -0.2% | $36.14 | $36.49 | $35.87 | 4,527,200 | |
| $36.28 | +0.12 | +0.3% | $36.70 | $36.70 | $35.78 | 6,028,100 | |
| $36.16 | +0.91 | +2.6% | $35.22 | $36.50 | $35.22 | 4,993,000 | |
| $35.25 | -0.53 | -1.5% | $36.00 | $36.00 | $34.56 | 5,841,828 | |
| $35.78 | -0.56 | -1.5% | $36.05 | $36.78 | $35.68 | 7,941,280 | |
| $36.34 | +1.22 | +3.5% | $35.88 | $36.44 | $35.62 | 6,743,400 | |
| $35.12 | +0.52 | +1.5% | $33.11 | $35.37 | $33.11 | 8,248,300 | |
| $34.60 | +0.01 | 0.0% | $34.89 | $35.56 | $34.35 | 5,856,700 | |
| $34.59 | +1.27 | +3.8% | $33.74 | $34.70 | $33.45 | 5,880,100 | |
| $33.32 | -0.59 | -1.7% | $33.23 | $33.43 | $32.47 | 5,986,700 | |
| $33.91 | -0.61 | -1.8% | $34.28 | $34.50 | $33.54 | 5,397,100 | |
| $34.52 | +1.65 | +5.0% | $33.39 | $34.54 | $33.01 | 4,555,300 |
- Ticker
- NASDAQ:ROIV
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
Roivant Social Ventures Announced Support of No Patient Left Behind with Six-Figure Organizational Legacy Gift
Latest earnings call · Aug 6, 2026
Roivant Sciences (NASDAQ:ROIV) Q1 2026 Earnings Call
Replay and transcript
Latest deck · Aug 28, 2026
Corporate Update (August 2026)
Corporate update · 27 slides
Calls
Upcoming
Roivant Sciences (NASDAQ:ROIV) Q2 2026 Earnings Call
Mon, Nov 09, 2026 · 8:00 AM ET
Register
Replays
Roivant Sciences (NASDAQ:ROIV) Q1 2026 Earnings Call
Thu, Aug 06, 2026 · 8:00 AM ET
Watch TranscriptRoivant Sciences (NASDAQ:ROIV) Q4 2025 Earnings Call
Wed, May 20, 2026 · 8:00 AM ET
Watch TranscriptRoivant Sciences (NASDAQ:ROIV) Q3 2025 Earnings Call
Fri, Feb 06, 2026 · 8:00 AM ET
Watch Transcript
Latest news
Roivant Social Ventures Announced Support of No Patient Left Behind with Six-Figure Organizational Legacy Gift
Oct 29, 2026
Closed $37.52 (+1.1%) on Oct 29, 2026
Roivant and Priovant Announce Positive Results in CLARITY-1 and CLARITY-2 Phase 3 Trials for Brepocitinib in Non-Infectious Uveitis (NIU)
Oct 21, 2026
Closed $36.80 (+5.4%) on Oct 21, 2026
Roivant to Report Financial Results for the Second Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026
Oct 21, 2026
Closed $36.80 (+5.4%) on Oct 21, 2026
Roivant Announces Topline Results from Proof-of-Concept Study of IMVT-1402 in Cutaneous Lupus Erythematosus
Sep 23, 2026
Closed $36.82 (-3.7%) on Sep 23, 2026
Roivant Announces Positive Results from PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) and Unveils Ongoing Phase 3 PHrontier Study
Sep 8, 2026
Closed $41.48 (+18.8%) on Sep 8, 2026
Roivant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on Tuesday, September 8, 2026, and Host Investor Call
Sep 6, 2026
Closed $41.48 (+18.8%) on Sep 8, 2026
Pulmovant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on Tuesday, September 8, 2026
Sep 6, 2026
Closed $41.48 (+18.8%) on Sep 8, 2026
Roivant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.
Aug 27, 2026
Closed $37.58 (+2.3%) on Aug 27, 2026
Roivant Reports Financial Results for the First Quarter Ended June 30, 2026, and Provides Business Update
Aug 6, 2026
Closed $35.12 (+1.5%) on Aug 6, 2026
Roivant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
Jul 23, 2026
Closed $35.01 (-0.3%) on Jul 24, 2026
Decks
Corporate Update (August 2026)
Corporate update · 27 slides · Aug 28, 2026
Q1 2026 Earnings Presentation
Earnings · 22 slides · Aug 6, 2026
Q3 2025 Earnings Presentation
Earnings · 32 slides · Feb 6, 2026
Investor Day (December 2025)
Investor day · 192 slides · Dec 11, 2025
Roivant Sciences Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 26 in the last 12 months · 116 in all · newest Oct 29, 2026 · oldest 2021
- Calls
- 20 calls with a replay · 20 with a transcript · latest Aug 6, 2026
- Decks
- 21 decks · latest Aug 28, 2026
Where Roivant Sciences Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ROIV · Home listing · This page | NASDAQ | United States | USD |
| gettex:87S | gettex | Germany | EUR |
| LS Exchange:A3C4MS | LS Exchange | Germany | EUR |
| Tradegate:87S | Tradegate | Germany | EUR |
| BX Swiss:ROIV | BX Swiss | Switzerland | CHF |
| Lang & Schwarz:A3C4MS | Lang & Schwarz | Germany | EUR |
| BOATS:ROIV | BOATS | United States | USD |
| Dusseldorf:87S | Dusseldorf | Germany | EUR |
| Frankfurt:87S | Frankfurt | Germany | EUR |
| Munich:87S | Munich | Germany | EUR |
| Stuttgart:87S | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Roivant Sciences Ltd.